Evidence map›Paper›PMID 42350397›Full record

ArticleNature communications2026

Ligand-controlled sequential activation enables nickel-catalysed alkyl-alkynyl coupling.

Nayeong Kim, Hyeri Jeon, Seungwoo Hong, Won Jun Jang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nayeong Kim *Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0006-7941-8304
Hyeri Jeon *Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.
Seungwoo HongDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea. hsw@ewha.ac.kr.ORCID http://orcid.org/0000-0001-7953-8433
Won Jun JangDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea. wonjunjang@ewha.ac.kr.ORCID http://orcid.org/0000-0002-0673-7607

Funding

Korea Basic Science Institute (KBSI) RS-2025-00563208National Research Foundation of Korea (NRF) RS-2021-NR060138National Research Foundation of Korea (NRF) RS-2024-00350505National Research Foundation of Korea (NRF) RS-2026-25485867
6 · The paper itself

Abstract

Cross-electrophile coupling between unactivated alkyl halides and alkynyl halides has long been challenged by reactivity mismatch and poor chemoselectivity. Here we report nickel-catalysed cross-electrophile coupling enabled by a tridentate ligand that controls the sequence of electrophile activation, allowing direct construction of alkynyl-alkyl bonds. This ligand-controlled strategy affords internal alkynes from unactivated primary, secondary, and tertiary alkyl halides with broad functional-group tolerance and enables reductive coupling of an unactivated tertiary alkyl electrophile with an alkynyl partner. Mechanistic studies reveal that the tridentate ligand enforces an unusual sequential activation pathway, in which the Ni(0) catalyst engages the alkyl halide prior to oxidative addition of the alkynyl partner. This alkyl-first activation mode ensures high chemoselectivity while suppressing homocoupling pathways, in contrast to conventional cross-electrophile coupling strategies that rely on rate-matching of electrophile reactivity. Overall, this study expands the scope of alkynyl-alkyl coupling and demonstrates how ligand control over activation sequence can enable challenging carbon-carbon bond-formation between mismatched electrophiles.

Identifiers

PMID42350397
PMCPMC13448636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.